US Medicare rejects routine coverage of warfarin genetic testing
11 May 2009
Sue Sutter
Please Login to read the full article.
11 May 2009
Sue Sutter
The US Medicare programme is proposing to pay for pharmacogenomic testing to predict a patient's response to warfarin only when conducted as part of an appropriately designed clinical trial.
In a proposed coverage decision, the
Centers for Medicare and Medicaid Services (CMS) said...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Panel insists government, industry can cozy up without being in bed together
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
- US Capitol Capsule: Health reform extends Medicare solvency, but programme to go bust by 2024
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
